NCT02437669View on ClinicalTrials.gov

Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Pain
Interventions
DRUG

Hydromorphone

To be administered by intranasal route using mucosal atomization device.

Trial Locations (1)

10032

Morgan Stanley Children's Hospital, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT02437669 - Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study. | Biotech Hunter | Biotech Hunter